Sentences with phrase «at the cancer centre»

Not exact matches

Other projects include the restoration of the Cancer Society Centre, Senior Citizen Centre and St Andrew's Kirk Elderly Home in The Bahamas; the construction of a new multipurpose room at Petite Savanne Primary School in Dominica; and the provision of school supplies to children in St Lucia.

SETTING The research team performed this research at the Royal Adelaide Hospital Cancer Centre, South Australia, Australia.

Scientists at the Institute of Food Research (IFR) and John Innes Centre in the UK have developed a heart disease and cancer - fighting broccoli.

Sian Lewis, Macmillan Clinical Lead Dietitian at the Velindre Cancer Centre, discusses the role oncology dietitians play in delivering the world class cancer strategy 2015 —Cancer Centre, discusses the role oncology dietitians play in delivering the world class cancer strategy 2015 —cancer strategy 2015 — 2020.

In collaboration with other public health and consumer organisations, the Cancer Council conducted 790 intercept surveys at shopping centres using mock food packages.

Tragically, the centre - back was diagnosed with pelvic cancer in 2011, and died at the age of 23 in 2012.

As a matter of urgency, we need to train more healthcare professional (doctors, nurses, and pharmacist) in paediatric oncology, expand treatment access to at least three others centres (Tamale, Cape Coast and Volta regions); and equip these facilities with good Labourites to be able to detect both solid and blood cancers.

Professor Robert West, Cancer Research UK's director of tobacco studies at the Health Behaviour Research Centre at UCL, said: «The smoke - free law has been a huge boost to smokers trying to quit, but radical action is now needed to build on this success.»

Dr Claudia Wellbrock, study author and Cancer Research UK scientist at The University of Manchester and a member of the Manchester Cancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow raCancer Research UK scientist at The University of Manchester and a member of the Manchester Cancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow raCancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow racancer cells spread by first specialising in invading other parts of the body and then change in order to grow rapidly.

Moreno was pulled back to Spain in 2005 by a 5 - year junior - leader position at the Spanish National Cancer Research Centre (CNIO) in Madrid.

Co-author Professor Fabio Levi (MD), Head of the Cancer Epidemiology Unit at the Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, (Switzerland), said: «Besides enforcing tobacco control — essentially by increasing taxation — national governments and EU policy makers must ensure that all EU citizens have access to the best screening, diagnosis and treatment, including those from central and eastern Europe where major delays are still observed and where cancer mortality rates tend to be higher as a result.&Cancer Epidemiology Unit at the Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, (Switzerland), said: «Besides enforcing tobacco control — essentially by increasing taxation — national governments and EU policy makers must ensure that all EU citizens have access to the best screening, diagnosis and treatment, including those from central and eastern Europe where major delays are still observed and where cancer mortality rates tend to be higher as a result.&cancer mortality rates tend to be higher as a result.»

International collaborators are located at Centre Leon Berard, Centre Antoine Lacassagne, and Institut Gustave Roussy, all in France; Fondazione IRCCS Istituto Nazionale Tumori, in Italy; The Institute of Cancer Research, in the United Kingdom; University Hospital Essen, in Germany; and National Cancer Center Hospital East and Kobe University Hospital, both in Japan.

The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research, London, and the Cancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingCancer Research UK Cambridge Centre, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of comingcancer that was at a low risk of coming back.

German police took action on 4 August after two patients from the Netherlands and one from Belgium died shortly after undergoing treatment at the Biological Cancer Centre, run by alternative practitioner Klaus Ross in the town of Brüggen, Germany, 50 kilometers west of Düsseldorf.

The findings — published today in Nature — provide significant insights into cell types fated to relapse and can help accelerate the quest for new, upfront therapies, says Dr. Dick, a Senior Scientist at Princess Margaret Cancer Centre, University Health Network, and Professor in the Department of Molecular Genetics, University of Toronto.

Scientists from the cluster of excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg and the Freiburg University Medical Center have shown that inhibiting the epigenetic regulator KDM4 might offer a potential novel treatment option for breast cancer patients.

Zachary Mainen, a neuroscientist at the Champalimaud Centre for the Unknown, a neuroscience and cancer research institute in Lisbon, speculated that we might expect an intelligent machine to suffer some of the same mental problems people do.

Events that cause inflammation in the body, such as an infection or smoking, are likely to have a role, says Stephen Baylin, deputy director of the cancer centre at Johns Hopkins Hospital in Baltimore, Maryland.

«Prostate cancers only kill men after they have spread or «metastasised» from the prostate,» says project leader Dr Luke Selth, Senior Research Fellow at the University of Adelaide's Dame Roma Mitchell Cancer Research Laboratories and a member of the Freemasons Foundation Centre for Men's Health.

Using genes from a snapdragon flower, a group led by Cathie Martin at the John Innes Centre in the UK created a tomato with unprecedented levels of anthocyanins, a kind of antioxidant that has been linked to reduced incidence of cancers.

Dr Gerrit - Jan Liefers (MD, PhD), a surgical oncologist and head of the geriatric oncology research group at Leiden University Medical Centre (Leiden, The Netherlands), said: «For a screening program to be effective, one would expect that the incidence of early stage breast cancer would increase while the incidence of advanced stage cancer would decrease because any cancer would have been detected at an earlier stage.

University of Calgary researchers including Luchman, Weiss and Dr. Greg Cairncross — director of SACRI, and leader of the Terry Fox Research Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblacancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblaCancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblastoma.

He endowed centres for advanced engineering and management at Massachusetts Institute of Technology, the Sloan - Kettering Cancer Center in New York and the foundation that bears his name.

It was funded by the Prostate Cancer Foundation, Prostate Cancer UK, Movember, Cancer Research UK and the National Institute for Health Research (NIHR) via the Experimental Cancer Medicine Centre network, and the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research (ICR).

Researchers at the Menzies Centre for Population Health Research in Hobart have found that in Tasmania between 1983 and 1992, there were almost twice as many lung cancer cases among women aged between 25 and 44 years as in men of the same age.

Produced by the UK Small Area Health Statistics Unit (SAHSU), part of the MRC - PHE Centre for Environment & Health based at Imperial College London, the open - access atlas allows researchers, policy makers and members of the public to study the geographical pattern of 14 diseases and conditions such as lung cancer, breast cancer, heart disease, leukemia and low birth weight.

Dr Fiona Blackhall, a senior lecturer in The University of Manchester's Institute of Cancer Sciences and a consultant based at The Christie NHS Foundation Trust — both part of the Manchester Cancer Research Centre — said: «In order to introduce precision medicine, where each cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.&Cancer Sciences and a consultant based at The Christie NHS Foundation Trust — both part of the Manchester Cancer Research Centre — said: «In order to introduce precision medicine, where each cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.&Cancer Research Centre — said: «In order to introduce precision medicine, where each cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.&cancer patient receives treatment designed to target the genetic makeup of their individual cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.&cancer, we need to compare how effective the new targeted treatment is compared to standard chemotherapy treatment.»

Presenting these results at the 3rd ESTRO Forum in Barcelona, Spain, today (Monday) Professor James Morris, from the Department of Radiation Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency (BCCA), Vancouver, Canada, will say that the ASCENDE - RT1 trial is the first and only existing trial comparing low - dose - rate prostate brachytherapy (LDR - PB) for the curative treatment of prostate cancer with any other method of radiation therapy delCancer Centre, British Columbia Cancer Agency (BCCA), Vancouver, Canada, will say that the ASCENDE - RT1 trial is the first and only existing trial comparing low - dose - rate prostate brachytherapy (LDR - PB) for the curative treatment of prostate cancer with any other method of radiation therapy delCancer Agency (BCCA), Vancouver, Canada, will say that the ASCENDE - RT1 trial is the first and only existing trial comparing low - dose - rate prostate brachytherapy (LDR - PB) for the curative treatment of prostate cancer with any other method of radiation therapy delcancer with any other method of radiation therapy delivery.

What was clear from this was that the cancer - related proteins tended to be very well connected at the centre of these networks, like a spider at the middle of its web.

However, the researchers, led by Dr Melanie Nichols, a Research Associate from the British Heart Foundation Centre on Population Approaches for Non-Communicable Disease Prevention at the University of Oxford (UK) and senior research fellow at Deakin University, Australia, found there were some countries where cancer was now causing more deaths than heart disease in men (Belgium, Denmark, France, Israel, Luxembourg, The Netherlands, Portugal, Slovenia, Spain and San Marino).

Commenting on the trial, Dr Alice Shaw, director of thoracic oncology at the Massachusetts General Hospital Cancer Centre in Boston, US, said: «This is the first randomised study to examine how a second generation ALK inhibitor compares to standard second line chemotherapy in ALK positive patients who failed the standard first line therapy, which currently is crizotinib.»

Dr. Pamela Ohashi, Director, Tumour Immunotherapy Program at the Princess Margaret Cancer Centre, University Health Network.

Other important bioinformatics centres are located at Wageningen University and at the Netherlands Cancer Institute in collaboration with the Academic Medical Centre in Amsterdam.

But the fact that there is «no long tradition in science is an advantage,» claims Erwin Wagner, director of the Cancer Cell Biology Programme at the Spanish National Cancer Research Centre (Centro Nacional de Investigaciones Oncológicas, CNIO) in Madrid.

Reporting the results from three trials of pembrolizumab for patients with advanced melanoma, Dr Marcus Butler, a medical oncologist at the Princess Margaret Cancer Centre, Toronto, Canada, told ECCO2017 that 84 of the 1567 patients in the KEYNOTE - 001, 002 and 006 studies had advanced mucosal melanoma.

Now researchers at University Hospital of South Manchester NHS Foundation Trust and The University of Manchester — part of the Manchester Cancer Research Centre — have looked at a newer technique: endobronchial ultrasound - guided transbronchial needle aspiration (EBUS - TBNA).

Leukemia researchers at Princess Margaret Cancer Centre have developed a 17 - gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.

The Genomic Instability Group at the Spanish National Cancer Research Centre (CNIO) has offered an explanation of this phenomenon and proposes a way to overcome it.

The findings, featured on the cover of the March 7 issue of Cell Reports, show that patients with high levels of the biomarker, CD151, have a poor prognosis, says lead author Mauricio Medrano, a molecular biologist and research associate at Princess Margaret Cancer Centre, University Health Network.

turned into 10 years of systematic research to identify the enzyme PLK4 as a promising therapeutic target and develop a small molecule inhibitor to block it,» says Dr. Mak, Director of The Campbell Family Institute for Breast Cancer Research at the Princess Margaret Cancer Centre, University Health Network.

The research, from the Cancer Research UK Health Behaviour Research Centre at UCL (University College London), is the largest study of its kind.

Researchers at Princess Margaret Cancer Centre have confirmed in a screening effectiveness study that early screening with MRIs can reduce breast cancer mortality for female survivors of childhood Hodgkin's lymphoma (HL) who received chest radiCancer Centre have confirmed in a screening effectiveness study that early screening with MRIs can reduce breast cancer mortality for female survivors of childhood Hodgkin's lymphoma (HL) who received chest radicancer mortality for female survivors of childhood Hodgkin's lymphoma (HL) who received chest radiation.

It was led by Dr. Tim Whelan, professor of oncology with McMaster University's Michael G. DeGroote School of Medicine and a radiation oncologist at Hamilton Health Sciences Juravinski Cancer Centre.

Cherny, an oncologist and palliative medicine specialist who is chair of humanistic medicine at Shaare Zedek Medical Centre, Jerusalem, Israel, added: «The designation also indicates that the centre is not only providing a clinical service but that it has programmes developed both to push the boundaries of knowledge through research and to teach the essential skills required for the provision of palliative care to cancer patients.&Centre, Jerusalem, Israel, added: «The designation also indicates that the centre is not only providing a clinical service but that it has programmes developed both to push the boundaries of knowledge through research and to teach the essential skills required for the provision of palliative care to cancer patients.&centre is not only providing a clinical service but that it has programmes developed both to push the boundaries of knowledge through research and to teach the essential skills required for the provision of palliative care to cancer patients.»

«We thought that patients who have CFS breaks might be more sensitive to radiation therapy - induced DNA damage,» said the lead author of the study, Robert G. Bristow, MD, PhD, a Professor within the radiation oncology and medical biophysics departments at the University of Toronto; and a Clinician - Scientist at the Princess Margaret Cancer Centre in Toronto.

The diagnosis and treatment of female cancers are known to affect fertility for several reasons: some chemotherapy regimens can cause damage to the ovary, and this can occur at any age; radiotherapy can also compromise female fertility through effects on the ovary, uterus and potentially those brain centres which control the reproductive axis.

The four - year study involved 461 patients at 24 medical oncology clinics at Princess Margaret Cancer Centre, University Health Network (UHN) with advanced lung, gastrointestinal, genitourinary, breast and gynecologic cancers.

The findings, published online today in the leading medical journal The Lancet, demonstrate the benefits of cancer centres providing early specialized palliative care in outpatient clinics, says principal investigator Dr. Camilla Zimmermann, Head, Palliative Care Program, UHN, and Medical Director, Al Hertz Centre for Supportive and Palliative Care at the Princess Margaret.

For example, a project in applied tumour virology at the German Cancer Research Centre was considered to be a special case.

Although most of the work has been carried out using in vivo studies, Asst Prof Gasser has been collaborating with Dr Joanne Ngeow at the National Cancer Centre Singapore to characterise the process in different types of human tumours.